Sung-Ung Kang, Dr.Med.Sc.

Consultant

Dr. Kang is an Assistant Professor in the Institute for Cell Engineering (ICE), Department of Neurology at the Johns Hopkins University School of Medicine (JHUSOM). He brings more than 20 years of expertise in Omics-based drug discovery research in neurodegenerative disorders. His current research aims to identify the key molecular hubs causing selective vulnerability in Parkinson’s disease (PD) and Alzheimer’s Disease (AD), which are crucial to identify discriminative markers for diagnosis and new treatment modalities.

Dr.Kang received his M.S. and B.S. in Biochemistry and Genetic engineering from SungKyunKwan University, Korea and Dr.Med.Sc. (equivalent M.D., Ph.D.) in Medicine and Neuroscience from Medical University of Vienna, Austria. As Post-doctoral fellow (2011-2014) and Research associate professor (2014-2018) at the Johns Hopkins Medicine, his research focused on understanding brain disorders using ‘omics’ profiling technology such as single-cell genomics and epigenomics.

Education

• Dr.Med.Sc. (equivalent M.D., Ph.D.), Medicine and Neuroscience, Medical University of Vienna, Austria
• M.S., Biochemistry and Genetic engineering, SungKyunKwan University,  Korea
• B.S., Biochemistry and Genetic engineering, SungKyunKwan University, Korea